pd 98059 has been researched along with Liver Steatosis in 2 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Zheng, C | 1 |
Zheng, Y | 1 |
Chen, X | 1 |
Zhong, X | 1 |
Zheng, X | 1 |
Yang, S | 1 |
Zheng, Z | 1 |
Kosone, T | 1 |
Takagi, H | 1 |
Horiguchi, N | 1 |
Ariyama, Y | 1 |
Otsuka, T | 1 |
Sohara, N | 1 |
Kakizaki, S | 1 |
Sato, K | 1 |
Mori, M | 1 |
2 other studies available for pd 98059 and Liver Steatosis
Article | Year |
---|---|
α-NETA down-regulates CMKLR1 mRNA expression in ileum and prevents body weight gains collaborating with ERK inhibitor PD98059 in turn to alleviate hepatic steatosis in HFD-induced obese mice but no impact on ileal mucosal integrity and steatohepatitis pro
Topics: Animals; Body Weight; Diet, High-Fat; Fatty Liver; Ileum; Intestinal Mucosa; Liver; Male; Mice; Mice | 2023 |
HGF ameliorates a high-fat diet-induced fatty liver.
Topics: Animals; Apolipoproteins B; Blood Glucose; Carrier Proteins; Dietary Fats; Fatty Liver; Flavonoids; | 2007 |